Aura Biosciences, Inc. ( AURA) - Key Metrics
AURA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.48 | -$0.34 | -$0.34 |
| 2026Q1 | $0 | -$0.50 | -$0.44 | -$0.44 |
| 2025Q4 | $0 | -$0.42 | -$0.34 | -$0.34 |
| 2025Q3 | $0 | -$0.40 | -$0.31 | -$0.31 |
| 2025Q2 | $0 | -$0.47 | -$0.36 | -$0.36 |
AURA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.70 |
| 2026Q1 | 0% | -3.35 |
| 2025Q4 | 0% | -3.41 |
| 2025Q3 | 0% | -3.86 |
| 2025Q2 | 0% | -3.33 |
AURA
Price: $6.27
52 week price:
Earnings Per Share: -1.73 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 120900
Market Capitalization: 661.0 million